TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 1 | -6 | -5 | 11 | 35 | -19 | 3 |
| P | %wins | 50 | 25 | 50 | 75 | 100 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/13/10 09:18 | 9/9/10 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schaller Charles R | MA | D | P | 17 | 3.45 | 3 | 5 | New | 5 | D | -68 | -37 | -33 | -32 | -32 | -21 | -19 | 1 | 13 | 8 | 27 | 20 | 10 | -23 | |
12/3/09 13:54 | 12/2/09 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schaller Charles R | MA | D | P | 33 | 4.69 | 1 | 7 | 5 | D | -21 | -14 | -57 | -14 | -4 | -12 | -5 | 2 | -2 | -1 | 1 | 10 | 41 | -12 | ||
11/12/09 16:09 | 11/10/09 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schaller Charles R | MA | D | P | 52 | 5.16 | 2 | 10 | 9 | D | -6 | -16 | -36 | -13 | -3 | 8 | 23 | 5 | 0 | -3 | -15 | -16 | 71 | -16 | ||
11/14/08 14:39 | 11/13/08 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schaller Charles R | SC | D | P | 18 | 6.11 | 0 | 3 | New | 3 | D | -59 | 27 | -54 | -55 | -38 | 10 | -6 | 10 | -9 | -29 | -34 | 30 | 18 | -23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |